Search research articles
Contact Us
Filters
Showing results (451-460 of 465) with videos related to
Page
of 47
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 14, 2020
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
The American Journal of Hospice & Palliative Care
|
January 8, 2019
Trauma Surgeon and Palliative Care Physician Attitudes Regarding Goals-of-Care Delineation for Injured Geriatric Patients
Holly B Cunningham, Shannon A Scielzo, Paul A Nakonezny, et al.
BMC Infectious Diseases
|
June 15, 2017
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study
Evan B Cunningham, Behzad Hajarizadeh, Olav Dalgard, et al.
Canadian Liver Journal
|
August 22, 2022
Striving toward hepatitis C elimination in the era of COVID-19
Charlotte Lanièce Delaunay, Zoë R Greenwald, Nanor Minoyan, et al.
The International Journal on Drug Policy
|
January 6, 2026
Interventions to improve testing, linkage to care, and treatment for hepatitis C infection in prison: a systematic review and meta-analysis
Evan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
JHEP Reports : Innovation in Hepatology
|
April 18, 2022
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals
Anita Y M Howe, Chaturaka Rodrigo, Evan B Cunningham, et al.
The International Journal on Drug Policy
|
June 24, 2025
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study
Joshua Ang, Behzad Hajarizadeh, Shane Tillakeratne, et al.
Environmental Science & Technology
|
February 10, 2022
In Situ Enhancement and Isotopic Labeling of Biogenic Coalbed Methane
Elliott P Barnhart, Leslie F Ruppert, Randy Hiebert, et al.
The International Journal on Drug Policy
|
November 2, 2018
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
Jason Grebely, Brian Conway, Evan B Cunningham, et al.
The International Journal on Drug Policy
|
October 24, 2018
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study
Evan B Cunningham, Janaki Amin, Jordan J Feld, et al.
Page
of 47
Search research articles
Search
Showing results (451-460 of 465) with videos related to
Sort By:
Page
of 47
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 14, 2020
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
The American Journal of Hospice & Palliative Care
|
January 8, 2019
Trauma Surgeon and Palliative Care Physician Attitudes Regarding Goals-of-Care Delineation for Injured Geriatric Patients
Holly B Cunningham, Shannon A Scielzo, Paul A Nakonezny, et al.
BMC Infectious Diseases
|
June 15, 2017
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study
Evan B Cunningham, Behzad Hajarizadeh, Olav Dalgard, et al.
Canadian Liver Journal
|
August 22, 2022
Striving toward hepatitis C elimination in the era of COVID-19
Charlotte Lanièce Delaunay, Zoë R Greenwald, Nanor Minoyan, et al.
The International Journal on Drug Policy
|
January 6, 2026
Interventions to improve testing, linkage to care, and treatment for hepatitis C infection in prison: a systematic review and meta-analysis
Evan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
JHEP Reports : Innovation in Hepatology
|
April 18, 2022
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals
Anita Y M Howe, Chaturaka Rodrigo, Evan B Cunningham, et al.
The International Journal on Drug Policy
|
June 24, 2025
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study
Joshua Ang, Behzad Hajarizadeh, Shane Tillakeratne, et al.
Environmental Science & Technology
|
February 10, 2022
In Situ Enhancement and Isotopic Labeling of Biogenic Coalbed Methane
Elliott P Barnhart, Leslie F Ruppert, Randy Hiebert, et al.
The International Journal on Drug Policy
|
November 2, 2018
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
Jason Grebely, Brian Conway, Evan B Cunningham, et al.
The International Journal on Drug Policy
|
October 24, 2018
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study
Evan B Cunningham, Janaki Amin, Jordan J Feld, et al.
Page
of 47